Hereditary Spastic Paraplegia: Clinical Trials

37 trials for Hereditary Spastic Paraplegia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 recruiting, 14 completed, 2 active not recruiting, 1 enrolling by invitation. 10 Not applicable, 3 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable10Recruiting 5, Completed 3, Enrolling by invitation 1, Withdrawn 1
Phase 23Completed 2, Not yet recruiting 1
Phase 12Completed 1, Not yet recruiting 1
Early Phase 11Recruiting 1
Phase 31Completed 1
Phase 41Completed 1

Follow Hereditary Spastic Paraplegia: new trials by email Literature Review of Hereditary Spastic Paraplegia trials Research Report on Hereditary Spastic Paraplegia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rare Disease Registry Database for Movement Disorders in Southern Anhui Province
Motor Neuron Diseases, Spinocerebellar Ataxias
RecruitingFirst Affiliated Hospital of Wannan Medical College1802026-09-302026-10-23
Neuromodulation to Enhance Motor Function in HSP
transcutaneous spinal cord stimulation - Hereditary Spastic Paraplegia
Not applicableRecruitingRahul Sachdeva152026-04-092026-04-22
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Whole-body Electrical Muscle Stimulation Exercise - Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not applicableRecruitingUniversity of Missouri-Columbia502026-03-102026-03-17
Dental-Oral and Craniofacial Characteristics of Hereditary Spastic Paraplegia: A Preliminary Study
Hereditary Spastic Paraplegia
CompletedUniversity of Barcelona502025-10-152026-09-02
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)
BFB-101 (AAV9-CBh-AP4B1) - HSP, Hereditary Spastic Paraplegia
Phase 1 / Phase 2Not yet recruitingBlackfinBio Ltd52025-08-012025-04-28
A Prospective Cohort Study of Surgical Treatment for Foot Deformities in HSP
Hereditary Spastic Paraplegia
RecruitingShanghai 6th People's Hospital1002025-03-012025-04-20
A Prospective Cohort Study of ITB Treatment for HSP
Hereditary Spastic Paraplegia
RecruitingShanghai 6th People's Hospital502025-01-012025-02-26
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Flexibility, Resistance, Aerobic, Movement Execution training - Hereditary Spastic Paraplegia
Not applicableRecruitingIRCCS Eugenio Medea202024-12-232025-01-30
TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias
Hereditary Spastic Paraplegia, Spastic Ataxia
RecruitingHeidelberg University40002024-07-162026-09-01
D-Cycloserine for Serine Palmitoyltransferase Inhibition
D-cycloserine - Hereditary Spastic Paraplegia
Phase 4CompletedMassachusetts General Hospital12024-07-102026-04-21
Calcium Folinate Treatment of Spastic Paraplegia 56
calcium folinate - Hereditary Spastic Paraplegia
Early Phase 1RecruitingShanghai 6th People's Hospital102024-07-012024-06-27
Spastic Paraplegia - Centers of Excellence Research Network
Hereditary Spastic Paraplegia, Primary Lateral Sclerosis
RecruitingBoston Children's Hospital1002024-06-042026-03-18
12-Week Strength and Functional Exercise Program for Hereditary Spastic Paraplegia Trial (HSPMOVE)
Individualized Functional and Strength Exercises - Hereditary Spastic Paraplegia
Not applicableEnrolling by invitationHospital de Clinicas de Porto Alegre202024-04-272026-05-01
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT) - Neuromuscular Diseases, Obesity (Disorder)
Not applicableRecruitingCentre Hospitalier Universitaire de Liege3002024-03-292025-08-22
STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
Hereditary Spastic Paraplegia
RecruitingIRCCS Fondazione Stella Maris5002024-01-242026-03-27
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
MTR-601 - Muscle Spasticity, Hypertonia, Muscle
Phase 1CompletedMotric Bio892023-09-112026-06-05
Natural History Study of Patients with HPDL Mutations
Patient Registry, Dry blood spots sampling - Mitochondrial Encephalomyopathies, Hereditary Spastic Paraplegia
RecruitingUniversity of California, San Diego502023-05-182025-03-30
A Pilot Study of Shockwave Therapy in HSP
Shockwave Therapy - Hereditary Spastic Paraplegia
Not applicableWithdrawnSpaulding Rehabilitation Hospital2023-01-012024-02-08
Identification of Modifying Factors in Hereditary Spastic Paraplegia
questionnaire completion - Hereditary Spastic Paraplegia
CompletedAssistance Publique - Hôpitaux de Paris3112022-10-042023-10-31
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Hereditary Spastic Paraplegia, Neurodegenerative Diseases
RecruitingBoston Children's Hospital2002022-04-252026-03-18

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Spastic Paraplegia, Hereditary (37)  ·  Motor Neuron Disease (8)  ·  Amyotrophic Lateral Sclerosis (5)  ·  Muscle Spasticity (5)  ·  Muscular Atrophy, Spinal (4)  ·  Neuromuscular Diseases (4)  ·  Spastic paraplegia 3, autosomal dominant (3)  ·  Cerebral Palsy (2)  ·  Charcot-Marie-Tooth Disease (2)  ·  Frontotemporal Dementia (2)  ·  Genetic Diseases, Inborn (2)  ·  Lambert-Eaton Myasthenic Syndrome (2)  ·  Movement Disorders (2)  ·  Muscular Dystrophy, Facioscapulohumeral (2)  ·  Myasthenia Gravis (2)

Broader conditions

Congenital Abnormalities (37)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (37)  ·  Hereditary Sensory and Motor Neuropathy (37)  ·  Heredodegenerative Disorders, Nervous System (37)  ·  Nervous System Diseases (37)  ·  Nervous System Malformations (37)  ·  Peripheral Nervous System Diseases (37)  ·  Polyneuropathies (37)  ·  Neurodegenerative Diseases (36)  ·  Genetic Diseases, Inborn (35)  ·  Neuromuscular Diseases (33)  ·  Central Nervous System Diseases (14)  ·  Brain Diseases (10)  ·  Neurologic Manifestations (10)  ·  Pathological Conditions, Signs and Symptoms (10)

Interventions

Physical Therapy Modalities (2)  ·  4-Aminopyridine (1)  ·  Blood Specimen Collection (1)  ·  Cycloserine (1)  ·  Extracorporeal Shockwave Therapy (1)  ·  Leucovorin (1)  ·  Pliability (1)  ·  Spinal Puncture (1)  ·  Walk Test (1)

Sponsors

Boston Children's Hospital (3)  ·  IRCCS Eugenio Medea (3)  ·  Shanghai 6th People's Hospital (3)  ·  University Hospital Tuebingen (3)  ·  IRCCS Fondazione Stella Maris (2)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (2)  ·  University of Miami (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  BlackfinBio Ltd (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Dr. Rebecca Schule (1)  ·  European University of Lefke (1)  ·  First Affiliated Hospital of Wannan Medical College (1)  ·  Heidelberg University (1)  ·  Hospital de Clinicas de Porto Alegre (1)

Countries

United States (13)  ·  Italy (7)  ·  Germany (6)  ·  China (4)  ·  Austria (2)  ·  Brazil (2)  ·  France (2)  ·  Netherlands (2)  ·  Poland (2)  ·  South Africa (2)  ·  Spain (2)  ·  Belgium (1)  ·  Cyprus (1)  ·  Czechia (1)  ·  Ireland (1)

Top investigators

Li Cao, phD (2)  ·  Michael Benatar, MD, PhD (2)  ·  Alan Hand, MD (1)  ·  Callyn Kirk, MSPH (1)  ·  Craig D Blackstone, M.D. (1)  ·  Darius Ebrahimi-Fakhari, MD, PhD (1)  ·  Ferda Selcuk (1)  ·  Filippo M Santorelli, Dr. (1)  ·  Filippo M Santorelli, MD PhD (1)  ·  Jakub M Antczak, MD (1)  ·  Jeffery Krischer, PhD (1)  ·  Jeffrey Statland, MD (1)  ·  Joseph Gleeson (1)  ·  Laurent Servais, MD (1)

Results publications

PMID 41491634, PMID 10540002, PMID 17030772, PMID 17364435, PMID 17709710, PMID 17980667, PMID 19833552, PMID 19922132, PMID 21706151, PMID 22507681, PMID 23421600, PMID 23944684, PMID 23952636, PMID 24067398, PMID 24070404, PMID 24778202, PMID 25054277, PMID 26205535, PMID 31214256, PMID 31646384, PMID 32139654, PMID 33101180, PMID 33413555, PMID 35472722, PMID 37804674, PMID 38058356, PMID 38291924, PMID 39185513, PMID 39270623, PMID 40040914, PMID 40368591, PMID 4056836, PMID 41199121, PMID 41667181, PMID 8229050, PMID 8302340, PMID 8423829, PMID 8639063, PMID 8858057

NIH funding

U54NS092091 (2), R01NS072248 (1), T32GM007748 (1), U01TR001263 (1)